---
schema_version: "secwatch.filing_event.v1"
accession: "0001516551-22-000052"
form_type: "8-K"
ticker: "SKYE"
cik: "0001516551"
company_name: "Skye Bioscience, Inc."
filed_at: "2022-11-23T23:59:59+00:00"
generated_at: "2026-06-21T13:23:15.005362+00:00"
event_type: "debt"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Skye Bioscience prepays $945K debt, extends maturity, reprices warrants to $0.017

## Summary
- Prepaid $944,862 of principal and interest; remaining convertible debt of $1.848M.
- Maturity of credit agreement extended to December 30, 2022.
- Exercise price of 16.6M Emerald warrants reduced from $0.50/$0.151 to $0.017 per share.
- Company agreed to negotiate registration rights for shares underlying warrants.
- Warrant repricing significantly increases potential future dilution for existing shareholders.

## SEC filing metadata
- accession: 0001516551-22-000052
- form_type: 8-K
- ticker: SKYE
- cik: 0001516551
- company_name: Skye Bioscience, Inc.
- filed_at: 2022-11-23T23:59:59+00:00
- event_type: debt
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 3.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1516551/000151655122000052/0001516551-22-000052-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1516551/000151655122000052/skye-20221117.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001516551-22-000052
- JSON: https://secwatch.observer/filing/0001516551-22-000052.json
- Plain text: https://secwatch.observer/filing/0001516551-22-000052.txt

## Key facts
- Material Agreements
  Skye Bioscience, Inc. amended Amendment and Acknowledgement Agreement with Emerald Health Sciences, Inc. (effective 2022-11-17).
  - Action: amendment
  - Agreement: credit facility
  - Counterparty: Emerald Health Sciences, Inc.
  - Effective: 2022-11-17
  source text: On November 17, 2022, Skye Bioscience, Inc. (the "Company") entered into an Amendment and Acknowledgement Agreement (the "Amendment Agreement") with Emerald Health Sciences, Inc. ("Emerald").
  evidence_url: https://www.sec.gov/Archives/edgar/data/1516551/000151655122000052/0001516551-22-000052-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.